However, the tested drugs include GLP-1 RA but not SGLT2i, and participation was not restricted to patients with newly diagnosed type 2 diabetes, resulting in an average baseline diabetes duration of approximately 4 years. Here, GLP1R is linked to type 2 diabetes mellitus.